Blood Cancer Clinical Trials & Research at Providence Medical Group

Chronic lymphocytic leukemia and multiple myeloma, blood cancers, represent a large group of different malignancies. This group includes cancers of the bone marrow, blood, and lymphatic system, which includes lymph nodes, lymphatic vessels, tonsils, thymus, spleen, and digestive tract lymphoid tissue. Leukemia and myeloma, which start in the bone marrow, and lymphoma, which starts in the lymphatic system, are the most common types of blood cancer. What causes these cancers is not known.

Providence Medical Group is currently enrolling patients for the following blood cancer clinical trials at this time:

---

Study for participants with previously untreated Chronic Lymphocytic Leukemia (Janssen Tailor)

Treatment agent: Ibrutinib treatment regimens
Physician: Dr Jarrod Holmes
Study Coordinator: Melissa Ulrich // melissa.ulrich@providence.org // 707-521-3830
Study Resources: Study Details | A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia | ClinicalTrials.gov
Sponsor: Janssen
Location: Providence Cancer Center Santa Rosa, CA